FLPKX
Price
$40.80
Change
+$0.41 (+1.02%)
Updated
May 8 closing price
Net Assets
21.63B
GVCAX
Price
$10.39
Change
+$0.01 (+0.10%)
Updated
May 8 closing price
Net Assets
207.03M
Ad is loading...

FLPKX vs GVCAX

Header iconFLPKX vs GVCAX Comparison
Open Charts FLPKX vs GVCAXBanner chart's image
Fidelity Low-Priced Stock K
Price$40.80
Change+$0.41 (+1.02%)
VolumeN/A
Net Assets21.63B
Gabelli Value 25 AAA
Price$10.39
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets207.03M
FLPKX vs GVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FLPKX vs. GVCAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLPKX is a Buy and GVCAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FLPKX has more cash in the bank: 21.6B vs. GVCAX (207M). FLPKX pays higher dividends than GVCAX: FLPKX (1.95) vs GVCAX (0.53). FLPKX was incepted earlier than GVCAX: FLPKX (17 years) vs GVCAX (15 years). GVCAX (1.49) is less costly to investors than FLPKX (0.82). FLPKX is a more actively managed with annual turnover of: 23.00 vs. GVCAX (5.00). FLPKX has a lower initial minimum investment than GVCAX: FLPKX (0) vs GVCAX (1000). GVCAX annual gain was more profitable for investors over the last year : 5.11 vs. FLPKX (-13.11). FLPKX return over 5 years is better than : 8.25 vs. GVCAX (-4.06).
FLPKXGVCAXFLPKX / GVCAX
Total Expense Ratio0.821.4955%
Annual Report Gross Expense Ratio0.821.4955%
Fund Existence17 years15 years-
Gain YTD-0.7135.274-14%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets21.6B207M10,435%
Annual Yield % from dividends1.950.53365%
Returns for 1 year-13.115.11-257%
Returns for 3 years-12.95-11.22115%
Returns for 5 years8.25-4.06-203%
Returns for 10 years-16.53-42.3939%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBDO2.400.30
+14.29%
Banco Bradesco SA
GLUE4.220.37
+9.61%
Monte Rosa Therapeutics
GRC37.751.07
+2.92%
Gorman-Rupp Company (The)
SNDR23.030.63
+2.81%
Schneider National
KALA3.43-0.02
-0.58%
Kala BIO